Randquist Charles, Por Yong Chen, Yeow Vincent, Maglambayan Joy, Simonyi Susan
Victoriakliniken, Saltsjöbaden, Sweden.
DREAM Aesthetics & Plastic Surgery, Singapore.
Arch Plast Surg. 2018 Jul;45(4):367-374. doi: 10.5999/aps.2018.00045. Epub 2018 Jul 15.
This analysis presents patient-reported outcomes of breast augmentation procedures performed in Singapore using an inframammary fold incision and the "5 Ps" best practice principles for breast augmentation. These data are the first of their kind in Southeast Asian patients.
Through a retrospective chart review, patients who underwent primary breast augmentation with anatomical form-stable silicone gel breast implants using an inframammary fold incision were followed for ≥6 months postoperatively. The BREAST-Q Augmentation Module (scores standardized to 0 [worst] - 100 [best]) and Patient and Observer Scar Assessment Scale (POSAS; 1 [normal skin] to 10 [worst scar imaginable]) were administered. Responses were summarized using descriptive statistics. Patient-reported events were collected.
Twenty-two Southeast Asian patients (mean age, 35.1 years) completed ≥1 postoperative BREAST-Q and POSAS assessment and were assessed 11 months to 5.5 years postoperatively. The mean postoperative BREAST-Q satisfaction with breasts and psychosocial well-being scores were 69.2 and 84.0, respectively. The mean POSAS score for their overall opinion of the scar was 4.2; the mean scores for all scar characteristics ranged from 1.2 to 4.2. Over 90% of patients (20/22) said that they would recommend the procedure. Patient complaints following surgery included anisomastia (possibly pre-existing; n=2), sensory loss at the nipple (n=2) or around the nipple (n=3), scarring (n=4), and slight capsular contracture (n=1). No patients required reoperation.
Southeast Asian patients reported high long-term satisfaction scores on the BREAST-Q scale and with their scar characteristics following breast augmentation using an inframammary fold incision, and nearly all said they would recommend this procedure. No reoperations were necessary in patients assessed for up to 5.5 years postoperatively.
本分析展示了在新加坡采用乳房下皱襞切口及“5P”隆胸最佳实践原则进行隆胸手术的患者报告结局。这些数据是东南亚患者中的首例此类数据。
通过回顾性病历审查,对采用乳房下皱襞切口、使用解剖型形状稳定硅胶乳房植入物进行初次隆胸手术的患者进行术后至少6个月的随访。使用乳房质量评估量表(BREAST-Q)隆胸模块(评分标准化为0[最差]-100[最佳])和患者及观察者瘢痕评估量表(POSAS;1[正常皮肤]至10[可想象的最差瘢痕])进行评估。使用描述性统计对回答进行总结。收集患者报告的事件。
22名东南亚患者(平均年龄35.1岁)完成了至少1次术后BREAST-Q和POSAS评估,术后评估时间为11个月至5.5年。术后BREAST-Q对乳房的平均满意度和心理社会幸福感评分分别为69.2和84.0。他们对瘢痕总体评价的平均POSAS评分为4.2;所有瘢痕特征的平均评分范围为1.2至4.2。超过90%的患者(20/22)表示他们会推荐该手术。术后患者的抱怨包括乳房不对称(可能为术前已存在;n=2)、乳头感觉丧失(n=2)或乳头周围感觉丧失(n=3)、瘢痕形成(n=4)和轻度包膜挛缩(n=1)。没有患者需要再次手术。
东南亚患者在BREAST-Q量表上报告了较高的长期满意度,且对采用乳房下皱襞切口进行隆胸后的瘢痕特征满意度较高,几乎所有患者都表示会推荐该手术。在术后长达5.5年接受评估的患者中,无需再次手术。